Literature DB >> 18593762

Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.

Beate Skinningsrud1, Eystein S Husebye, Simon H Pearce, David O McDonald, Kristin Brandal, Anette B Wolff, Kristian Løvås, Thore Egeland, Dag E Undlien.   

Abstract

CONTEXT/
OBJECTIVES: It is known that different autoimmune diseases often share the same susceptibility genes. In this study we aimed to investigate if loci found associated with common autoimmune diseases in recent genome-wide association studies also could be susceptibility loci for autoimmune Addison's disease (primary adrenal insufficiency). DESIGN/PATIENTS: A total of 139 tagging single nucleotide polymorphisms (SNPs) in 11 candidate genes (IL2, IL21, IL2RA, CLEC2D, CD69, ERBB3, PTPN11, SH2B3, CLEC16A, CIITA, and PTPN2) were genotyped in a case/control study design consisting of Norwegian Addison's disease patients (n = 332) and Norwegian healthy control individuals (n = 1029). Five SNPs were subsequently selected for analysis in a United Kingdom sample set consisting of Addison's disease patients (n = 210) and controls (n = 191).
RESULTS: Polymorphisms in CLEC16A and CIITA remained significantly associated with Addison's disease in the Norwegian sample set at the 0.05 level, even after correction for multiple testing. CLEC16A and CIITA are both located at 16p13, but linkage disequilibrium patterns and logistical regression analyses suggest that SNPs in these two genes are independently associated with Addison's disease. We were not able to confirm these associations in the United Kingdom material, however, this may well be due to the limited sample size and lack of statistical power.
CONCLUSION: Two alleles at 16p13 are independently associated with the risk of Addison's disease in the Norwegian population, suggesting this chromosomal region to harbor common autoimmunity gene(s), CLEC16A and CIITA being possible independent candidates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593762     DOI: 10.1210/jc.2008-0821

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.

Authors:  Kavita Purnanda Bhat; Agnieszka Dorota Truax; Susanna Fletcher Greer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 2.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

3.  The Autoimmunity-Associated Gene CLEC16A Modulates Thymic Epithelial Cell Autophagy and Alters T Cell Selection.

Authors:  Cornelia Schuster; Kay D Gerold; Kilian Schober; Lilli Probst; Kevin Boerner; Mi-Jeong Kim; Anna Ruckdeschel; Thomas Serwold; Stephan Kissler
Journal:  Immunity       Date:  2015-05-12       Impact factor: 31.745

Review 4.  Recent advances in the genetics of systemic lupus erythematosus.

Authors:  Donna L Thibault Flesher; Xin Sun; Timothy W Behrens; Robert R Graham; Lindsey A Criswell
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

5.  Variability in the CIITA gene interacts with HLA in multiple sclerosis.

Authors:  A Gyllenberg; F Piehl; L Alfredsson; J Hillert; I L Bomfim; L Padyukov; M Orho-Melander; E Lindholm; M Landin-Olsson; Å Lernmark; T Olsson; I Kockum
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

Review 6.  The potential role for infections in the pathogenesis of autoimmune Addison's disease.

Authors:  A Hellesen; E Bratland
Journal:  Clin Exp Immunol       Date:  2018-09-30       Impact factor: 4.330

7.  The expanding genetic overlap between multiple sclerosis and type I diabetes.

Authors: 
Journal:  Genes Immun       Date:  2008-11-06       Impact factor: 2.676

8.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus.

Authors:  Vesela Gateva; Johanna K Sandling; Geoff Hom; Kimberly E Taylor; Sharon A Chung; Xin Sun; Ward Ortmann; Roman Kosoy; Ricardo C Ferreira; Gunnel Nordmark; Iva Gunnarsson; Elisabet Svenungsson; Leonid Padyukov; Gunnar Sturfelt; Andreas Jönsen; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Emily C Baechler; Elizabeth E Brown; Graciela S Alarcón; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Gerald McGwin; John D Reveille; Luis M Vilá; Robert P Kimberly; Susan Manzi; Michelle A Petri; Annette Lee; Peter K Gregersen; Michael F Seldin; Lars Rönnblom; Lindsey A Criswell; Ann-Christine Syvänen; Timothy W Behrens; Robert R Graham
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

9.  The novel endosomal membrane protein Ema interacts with the class C Vps-HOPS complex to promote endosomal maturation.

Authors:  Sungsu Kim; Yogesh P Wairkar; Richard W Daniels; Aaron DiAntonio
Journal:  J Cell Biol       Date:  2010-03-01       Impact factor: 10.539

10.  A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis.

Authors:  Beate Skinningsrud; Benedicte A Lie; Eystein S Husebye; Tore K Kvien; Øystein Førre; Berit Flatø; Alice Stormyr; Geir Joner; Pål R Njølstad; Thore Egeland; Dag E Undlien
Journal:  Ann Rheum Dis       Date:  2009-09-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.